Wirth LJ - Search Results

1

Tuttle RM, Ball DW, Byrd D, Dilawari RA, Doherty GM, Duh QY, Ehya H, Farrar WB, Haddad RI, Kandeel F, Kloos RT, Kopp P, Lamonica DM, Loree TR, Lydiatt WM, McCaffrey JC, Olson JA Jr, Parks L, Ridge JA, Shah JP, Sherman SI, Sturgeon C, Waguespack SG, Wang TN, Wirth LJ; National Comprehensive Cancer Network. Tuttle RM, et al. Among authors: wirth lj. J Natl Compr Canc Netw. 2010 Nov;8(11):1228-74. doi: 10.6004/jnccn.2010.0093. J Natl Compr Canc Netw. 2010. PMID: 21081783 No abstract available.

2

Integration of chemotherapy in the curative treatment of locally advanced head and neck cancer.

Haddad RI, Wirth L, Posner MR. Haddad RI, et al. Expert Rev Anticancer Ther. 2003 Jun;3(3):331-8. doi: 10.1586/14737140.3.3.331. Expert Rev Anticancer Ther. 2003. PMID: 12820776 Review.

3

Progress and perspectives in chemoprevention of head and neck cancer.

Wirth LJ, Haddad RI, Posner MR. Wirth LJ, et al. Expert Rev Anticancer Ther. 2003 Jun;3(3):339-55. doi: 10.1586/14737140.3.3.339. Expert Rev Anticancer Ther. 2003. PMID: 12820777 Review.

4

Phase II randomized study of concomitant chemoradiation using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with newly diagnosed locally advanced squamous cell carcinoma of the head and neck.

Haddad R, Wirth L, Costello R, Weeks L, Posner M. Haddad R, et al. Semin Oncol. 2003 Dec;30(6 Suppl 18):84-8. doi: 10.1053/j.seminoncol.2003.11.011. Semin Oncol. 2003. PMID: 14727246 Clinical Trial.

5

Induction chemotherapy in locally advanced squamous cell cancer of the head and neck: evolution of the sequential treatment approach.

Posner MR, Haddad RI, Wirth L, Norris CM, Goguen LA, Mahadevan A, Sullivan C, Tishler RB. Posner MR, et al. Semin Oncol. 2004 Dec;31(6):778-85. doi: 10.1053/j.seminoncol.2004.09.007. Semin Oncol. 2004. PMID: 15599855 Review.

6

Phase I study of gefitinib plus celecoxib in recurrent or metastatic squamous cell carcinoma of the head and neck.

Wirth LJ, Haddad RI, Lindeman NI, Zhao X, Lee JC, Joshi VA, Norris CM Jr, Posner MR. Wirth LJ, et al. J Clin Oncol. 2005 Oct 1;23(28):6976-81. doi: 10.1200/JCO.2005.02.4182. Epub 2005 Sep 19. J Clin Oncol. 2005. PMID: 16172459 Clinical Trial.

7

Chemoradiotherapy for adenoid cystic carcinoma: preliminary results of an organ sparing approach.

Haddad RI, Posner MR, Busse PM, Norris CM Jr, Goguen LA, Wirth LJ, Blinder R, Krane JF, Tishler RB. Haddad RI, et al. Among authors: wirth lj. Am J Clin Oncol. 2006 Apr;29(2):153-7. doi: 10.1097/01.coc.0000203756.36866.17. Am J Clin Oncol. 2006. PMID: 16601434

8

Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancer.

Goguen LA, Posner MR, Tishler RB, Wirth LJ, Norris CM, Annino DJ, Sullivan CA, Li Y, Haddad RI. Goguen LA, et al. Among authors: wirth lj. Arch Otolaryngol Head Neck Surg. 2006 May;132(5):526-31. doi: 10.1001/archotol.132.5.526. Arch Otolaryngol Head Neck Surg. 2006. PMID: 16702569

9

Rate of pathologic complete responses to docetaxel, cisplatin, and fluorouracil induction chemotherapy in patients with squamous cell carcinoma of the head and neck.

Haddad R, Tishler R, Wirth L, Norris CM, Goguen L, Sullivan C, O'Donnell L, Li Y, Posner M. Haddad R, et al. Arch Otolaryngol Head Neck Surg. 2006 Jun;132(6):678-81. doi: 10.1001/archotol.132.6.678. Arch Otolaryngol Head Neck Surg. 2006. PMID: 16785415

10

Emerging drugs for head and neck cancer.

Haddad R, Wirth L, Posner M. Haddad R, et al. Expert Opin Emerg Drugs. 2006 Sep;11(3):461-7. doi: 10.1517/14728214.11.3.461. Expert Opin Emerg Drugs. 2006. PMID: 16939385 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

181 results

Search Page

Filters